Higati Eye Ointment

Introduction

Higati is a topical medication that contains the active ingredient Gatifloxacin. It is available under the brand name Higati. This ointment is primarily used to treat certain types of eye infections caused by bacteria.

Uses

Higati is prescribed for the treatment of bacterial conjunctivitis, commonly known as pink eye. This condition is characterized by redness, itching, and discharge in the eyes. By targeting the bacteria responsible for the infection, Higati helps alleviate the symptoms and promote healing.

Dosage and Administration

Before applying Higati, wash your hands thoroughly. Gently pull down the lower eyelid to create a small pocket and squeeze a thin strip of ointment into the pocket. Blink a few times to spread the ointment evenly across the eye.

The recommended dosage for Higati is usually one application three times daily, or as directed by your healthcare provider. Complete the full course of treatment, even if symptoms improve before the treatment is finished.

Mechanism of Action

Gatifloxacin, the active ingredient in Higati, belongs to a class of medications called fluoroquinolone antibiotics. It works by inhibiting the growth and reproduction of bacteria, thereby preventing the spread of infection. This mechanism of action helps to clear the bacterial infection and relieve the associated symptoms.

Side Effects

Common side effects may include temporary burning or stinging sensation in the eyes, blurred vision, or eye discomfort. These side effects are usually mild and go away on their own.

Serious side effects are rare but can occur. If you experience severe eye pain, vision changes, swelling, or signs of an allergic reaction such as rash, itching, or difficulty breathing, seek medical attention immediately.

Drug Interactions

inform your healthcare provider about all the medications you are currently taking, including prescription drugs, over-the-counter medications, and herbal supplements. Certain medications may interact with Higati, potentially affecting its effectiveness or increasing the risk of side effects. Be sure to discuss any potential drug interactions with your healthcare provider.

Precautions

Before using Higati, inform your healthcare provider if you have any allergies, especially to fluoroquinolone antibiotics. Let your healthcare provider know if you have any other medical conditions, such as glaucoma or any other eye problems.

Avoid touching the tip of the ointment tube to any surface, including the eye, to prevent contamination. If you wear contact lenses, remove them before applying the ointment and wait at least 15 minutes before reinserting them.

Storage

Higati should be stored at room temperature, away from excessive heat and moisture. Keep the tube tightly closed when not in use. Do not use the ointment if it has passed the expiration date printed on the packaging.

Patient Tips

Here are a few tips to help you make the most of your treatment with Higati:

• Follow the instructions provided by your healthcare provider for the correct dosage and application technique.
• Avoid touching your eyes with unwashed hands to prevent the spread of infection.
• If you experience any persistent or worsening symptoms, or if your condition does not improve after a few days of treatment, contact your healthcare provider.
• Do not share your medication with others, as it is specifically prescribed for your condition.
• If you have any concerns or questions about your treatment, do not hesitate to consult your healthcare provider for further guidance.

Please note that this description, as well as the other content on our website is for educational purposes only. We do not provide medical advice. For specific medical advices, diagnoses and treatment options you should consult with your doctor.

References

• Gatifloxacin ophthalmic (Drugs.com) [Accessed 19 Jun. 2024] (online) Available at:
• gatifloxacin drops (RX) [Accessed 15 Jun. 2024] (online) Available at:
• Gatifloxacin Ophthalmic (MedlinePlus) [Accessed 4 Jun. 2024] (online) Available at:
• Perry CM, Barman Balfour JA, Lamb HM. Gatifloxacin. Drugs. 1999 Oct;58(4):683-96; discussion 697-8. doi: 10.2165/00003495-199958040-00010. [Accessed 29 Jun. 2024] Available at: